The Development of Probody Therapeutics for the Targeting of Cancer

The Development of Probody Therapeutics for the Targeting of Cancer

0 0 circa un anno fa
In this edition of The OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo talk Sean McCarthy, D.Phil, President and Chief Executive Officer of CytomX, a biotechnology company developing a novel 'Probody Platform' which allows them to design therapeutic drugs that selectively activate in the tumor microenvironment while reducing drug activity in healthy tissue and in circulation.

In addition to his work for CytomX, McCarthy is the author on multiple peer-reviewed scientific ... Maggiori informazioni

Seguici su Facebook

iAB member
Copyright 2019 - Spreaker Inc. a Voxnest Company - Crea un podcast - New York, NY
Aiuto